Europe PMC
open access
CC BY 4.0
Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prescriptions for Responsible Psychiatry#115383
- Endocannabinoid system and skeletal muscle health: Insights from cannabidiol#408781
- The Brain Endocannabinoid System is Differentially Regulated in Male and Female Patients with First-Episode Psychosis.#157881
- CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr#917444
- Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)#1126296
Record · ID 398612
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive